Showing results (1111-1120 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 6, 1997
Is Helicobacter pylori eradication a cost-effective treatment of duodenal ulcer disease?M O Carrere, H Lamouliatte, P RuszniewskiPharmacoeconomics|February 6, 1997
A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipientsD C Brennan, M A Schnitzler, J D Baty, et al.Pharmacoeconomics|February 6, 1997
Measuring the variability of prescription use in patients with HIV infection or AIDS. The contribution of a French hospital longitudinal databaseM Kerleau, M Le Vaillant, Y A FloriPharmacoeconomics|January 7, 1997
The economics of osteoporosis and its prevention. A reviewD J Torgerson, D M ReidPharmacoeconomics|March 8, 1997
Will managed care work in Europe?E Mossialos, P Kanavos, B Abel-SmithPharmacoeconomics|March 8, 1997
Cost-effectiveness analysis of different strategies for treating duodenal ulcer. Helicobacter pylori eradication versus antisecretory treatmentX Badia, J L Segú, A Ollé, et al.Pharmacoeconomics|May 7, 1997
Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 2: Cost-effectiveness analysesJ A Henry, C A RivasPharmacoeconomics|June 6, 1997
Drug policy in China. Transformations, current status and future prospectsX Liu, S LiPharmacoeconomics|July 6, 1997
Cost considerations in patient-controlled analgesiaA Jacox, D B Carr, D M Mahrenholz, et al.Pharmacoeconomics|July 6, 1997
Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorderT R Einarson, A Addis, M IskedjianPageof 336